y5
2304444-48-0
|
Y6-OD-2Br
2418532-43-9
|
Org OD 13-0
4781-53-7
|
Cyclohexanol-OD
121621-82-7
|
Neuropeptide Y5 receptor ligand-1
322723-35-3
|
propionic acid-od
21388-62-5
|
dichloroacetic acid-od
82093-18-3
|
Dimethyl Hemiorthoformiat (OD)
73761-37-2
|
3-nitrobenzyl alcohol-od
117897-59-3
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
tert-Butyl-DL-alanine
1375289-11-4
|
3-Methoxy-2-[2-(2-methylphenoxy)ethoxy]benzaldehyde
299935-16-3
|
2-Fluoro-2-phenyl-propionic acid ethyl ester
122795-14-6
|
